179 results
DEFA14A
IBRX
ImmunityBio Inc
29 Apr 24
Additional proxy soliciting materials
4:20pm
as ImmunityBio’s independent registered public accounting firm for the fiscal year ending December 31, 2024. For NOTE: In their discretion, the proxies
S-3ASR
EX-23.1
IBRX
ImmunityBio Inc
17 Apr 24
Automatic shelf registration
5:24pm
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts
S-3ASR
EX-4.3
IBRX
ImmunityBio Inc
17 Apr 24
Automatic shelf registration
5:24pm
of independent certified public accountants or investment bank expressed in a written certification thereof delivered to the Trustee, are then in excess … , sufficient, in the opinion of a nationally recognized firm of independent public accountants or investment bank expressed in a written certification
S-3ASR
IBRX
ImmunityBio Inc
17 Apr 24
Automatic shelf registration
5:24pm
writing prospectus may contain and incorporate by reference, market data and industry statistics and forecasts that are based on independent industry … of independent public accountants or investment bank to pay and discharge each installment of principal, premium and interest on and any mandatory sinking fund
424B5
mimn7
24 Jul 23
Prospectus supplement for primary offering
5:12pm
8-K
EX-4.1
vs495yjdn6oh4a ozbrt
21 Jul 23
ImmunityBio Announces Execution of $40 Million Equity Financing with Institutional Investors
6:04am
8-K
EX-10.1
1ne 8e15kg2pui4
21 Jul 23
ImmunityBio Announces Execution of $40 Million Equity Financing with Institutional Investors
6:04am
8-K
EX-1.1
603ix7738q7w9ke7i
21 Jul 23
ImmunityBio Announces Execution of $40 Million Equity Financing with Institutional Investors
6:04am
8-K
gomo8yk0zzaumn
14 Jun 23
Entry into a Material Definitive Agreement
5:15pm